Osobní účet
Osobní účet
O společnosti
Total Funding
$171.3M
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders. The company leverages its expertise in neuroscience, translational medicine, and clinical development to meet this unmet medical need with a highly innovative pipeline.
Eliem Therapeutics develops and commercializes potentially “best-in-class” drug candidates to treat neuronal excitability disorders. These conditions—such as chronic pain, depression, epilepsy, and anxiety—cause deep suffering for tens of millions of people each day. At its core, the Eliem team is motivated by the promise of helping patients live happier, more fulfilling lives.
Number of employees
10 - 50
Headquarters
Redmond, WA, US
Upisovatelé
Intermediate Capital Group, RA Capital Management, Access Biotechnology, Intermediate Capital Group, RA Capital Management